Brainstorm Cell regains Nasdaq minimum market value compliance

BRAINSTORM CELL THERAPEUTICS INC.

Received Nasdaq notification on April 10, 2024 that it regained compliance with Listing Rule 5550(b)(2).
Market value of listed securities was >= $35M for 11 consecutive business days (Mar 22 – Apr 9, 2024).
Previous deficiency notice received November 6, 2023; matter now closed.
Continued listing on Nasdaq Capital Market is no longer in jeopardy.
Press release issued April 11, 2024 confirms compliance reinstatement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.